This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Foley RN et al. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3): S112–S119
Holdaas H et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361: 2024–2031
Jardine AG et al. (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am J Transplant 4: 988–995
Kasiske B et al. (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients. A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 (Suppl 7): S13–S53
Cosio FG et al. (2002) Patient survival after renal transplantation III: the effects of statins. Am J Kidney Dis 40: 638–643
Acknowledgements
The synopsis was written by Rachael Williams, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Morales, J. Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?. Nat Rev Nephrol 1, 78–79 (2005). https://doi.org/10.1038/ncpneph0050
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0050